Page 7 - அலுவலகம் ஆஃப் புற்றுநோயியல் நோய்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA Approves First Oral Hormone Therapy for Treating Advanced Prostate Cancer

December 18, 2020 Today, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer. “Today’s approval marks the first oral drug in this class and it may eliminate some patients’ need to visit the clinic for treatments that require administration by a health care provider,” said Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence and acting director of the Office of Oncologic Diseases in the FDA’s Center for Drug Evaluation and Research. “This potential to reduce clinic visits can be especially beneficial in helping patients with cancer stay home and avoid exposure during the coronavirus pandemic.”

United statesRichard pazdurOncology centerUs department of healthHuman servicesOrgovyx to myovant sciencesDrug administrationOffice of oncologic diseasesAmerican cancer societyFor immediate releaseOncologic diseasesDrug evaluationஒன்றுபட்டது மாநிலங்களில்புற்றுநோயியல் மையம்எங்களுக்கு துறை ஆஃப் ஆரோக்கியம்மனிதன் சேவைகள்

FDA Approves First Adjuvant Therapy for Most Common Type of Lung Cancer

December 18, 2020 Today, the U.S. Food and Drug Administration approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation. Today’s approval of Tagrisso demonstrates how additional research on therapies approved in later stages of cancer can eventually improve treatment options for patients in earlier stages,” said Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence and acting director of the Office of Oncologic Diseases in the FDA’s Center for Drug Evaluation and Research. “With this approval, patients may be treated with this targeted therapy in an earlier and potentially more curative stage of non-small cell lung cancer.”

Richard pazdurOncology centerUs department of healthHuman servicesDrug administrationSingapore health sciences authorityAustralian therapeutic goods administrationBrazilian health regulatory agencyHealth canadaOffice of oncologic diseasesFor immediate releaseOncologic diseasesDrug evaluationOrphan drugBreakthrough therapyProject orbis

FDA OKs First Oral Hormone Tx for Advanced Prostate Cancer

FDA OKs First Oral Hormone Tx for Advanced Prostate Cancer
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

Myrtle beachSouth carolinaUnited statesNew yorkRichard pazdurLangone healthAmerican society of clinical oncologyCarolina urologic research centerDrug administrationOffice of oncologic diseasesPerlmutter cancer centerOncologic diseasesDrug evaluationAmerican societyClinical oncologyNew england journal

Oral Therapy for Patients With Prostate Cancer Granted FDA Approval

Oral Therapy for Patients With Prostate Cancer Granted FDA Approval
pharmacytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmacytimes.com Daily Mail and Mail on Sunday newspapers.

United statesRichard pazdurOncology centerMyovant sciencesOffice of oncologic diseasesAmerican cancer societyOncologic diseasesDrug evaluationஒன்றுபட்டது மாநிலங்களில்புற்றுநோயியல் மையம்அலுவலகம் ஆஃப் புற்றுநோயியல் நோய்கள்அமெரிக்கன் புற்றுநோய் சமூகம்புற்றுநோயியல் நோய்கள்மருந்து மதிப்பீடு